BIOM VG Life Sciences Inc.

Fundamentals / CIK 0001091326 / USD
Other share classes on CIK 0001091326: VGLS VGLSD

VG Life Sciences Inc. reported $0 in revenue and a net loss of $4.30M for the trailing twelve months ended September 30, 2015.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BIOM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2013 to 2014), reported in USD.

$0$0$0-$6.94MFY 2013 Revenue: $0FY 2013 Net Income: -$7.42M2013FY 2014 Revenue: $0FY 2014 Net Income: -$6.19M2014

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Revenue $0 $0
Research & Development $866K $809K
Operating Income -$4.14M -$3.91M
EBITDA -$4.14M -$3.91M
Interest Expense $2.76M $1.08M
Income Tax Expense $0 $0
Net Income -$6.19M -$7.42M
Basic EPS -$0.22 -$0.91
Diluted EPS -$0.22 -$0.91
Basic Shares Outstanding 27.6M 8.2M
Diluted Shares Outstanding 27.6M 8.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30
Revenue $0 $0 $0 $0 $0 $0 $0 $0
Research & Development $140K $163K $160K -$110K $340K $224K $412K $300K
Operating Income -$644K -$739K -$801K -$541K -$799K -$1.15M -$1.65M -$854K
EBITDA -- -- -- -- -$799K -- -- -$854K
Interest Expense $250K $432K $715K $666K $688K $554K $852K $72K
Net Income -$1.01M -$1.40M -$1.46M -$424K -$1.06M -$2.00M -$2.70M -$1.55M
Basic EPS -$0.01 -$0.02 -$0.03 -- -$0.04 -$0.09 -$0.14 -$0.18
Diluted EPS -$0.01 -$0.02 -$0.03 -- -$0.04 -$0.09 -$0.14 -$0.18
Basic Shares Outstanding 85.5M 66.9M 51.6M -- 28.9M 22.8M 18.9M 8.4M
Diluted Shares Outstanding 85.5M 66.9M 51.6M -- 28.9M 22.8M 18.9M 8.4M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $34K $714K
Cash & Short-Term Investments $34K $714K
Total Current Assets $246K $789K
Property, Plant & Equipment, Net $0 $0
Intangible Assets $1.08M $1.08M
Total Non-Current Assets $1.08M $1.08M
Total Assets $1.32M $1.87M
Accounts Payable $710K $405K
Total Current Liabilities $5.83M $6.33M
Total Non-Current Liabilities $0 $0
Total Liabilities $5.83M $6.33M
Common Stock $4.6K $1.7K
Retained Earnings -$106.0M -$99.78M
Total Stockholders' Equity -$4.51M -$4.47M
Total Equity -$4.51M -$4.47M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2013-12-31
Cash & Cash Equivalents $23K $4.3K $30K $34K $54K $714K
Cash & Short-Term Investments $23K $4.3K $30K $34K $54K $714K
Total Current Assets $40K $39K $92K $246K $60K $789K
Property, Plant & Equipment, Net $0 $0 $0 $0 $0 $0
Intangible Assets $1.08M $1.08M $1.08M $1.08M $1.08M $1.08M
Total Non-Current Assets $1.08M $1.08M $1.08M $1.08M $1.08M $1.08M
Total Assets $1.12M $1.12M $1.17M $1.32M $1.14M $1.87M
Accounts Payable $837K $726K $685K $710K $866K $405K
Total Current Liabilities $5.46M $5.96M $5.89M $5.83M $6.31M $6.33M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0
Total Liabilities $5.46M $5.96M $5.89M $5.83M $6.31M $6.33M
Common Stock $10K $7.7K $6.1K $4.6K $3.1K $1.7K
Retained Earnings -$109.8M -$108.8M -$107.4M -$106.0M -$105.5M -$99.78M
Total Stockholders' Equity -$4.34M -$4.84M -$4.73M -$4.51M -$5.17M -$4.47M
Total Equity -$4.34M -$4.84M -$4.73M -$4.51M -$5.17M -$4.47M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$6.22M -$7.48M
Depreciation & Amortization $0 $0
Stock-Based Compensation $0 $0
Change in Payables $317K $75K
Operating Cash Flow -$1.91M -$1.04M
Capital Expenditure $0 $0
Free Cash Flow -$1.91M -$1.04M
Investing Cash Flow $0 $0
Common Stock Issued $0 $0
Financing Cash Flow $1.23M $1.75M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30
Net Income -$1.02M -$1.41M -$1.47M -$433K -$1.07M -$2.01M -$2.71M -$1.56M
Depreciation & Amortization -- -- -- -- $0 -- -- $0
Stock-Based Compensation $63K $86K $92K -- -- -- -- --
Change in Payables $115K $41K $12 -$145K $2.8K $202K $256K --
Operating Cash Flow -$48K -$238K -$165K -$407K -$468K -$309K -$725K --
Financing Cash Flow $67K $212K $161K $388K $489K $193K $160K --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Return on Assets (ROA) -467.8% -397.6%
Current Ratio 0.04x 0.12x
Quick Ratio 0.01x 0.11x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30
Return on Assets (ROA) -384.8% -389.6% -423.3% -467.8% -- -- -- --
Current Ratio 0.01x 0.01x 0.02x 0.04x 0.01x -- -- --
Quick Ratio 0.00x 0.00x 0.01x 0.01x 0.01x -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001091326) · from September 30, 2013 Data through September 30, 2015 · synced Nov 21, 2026, 05:03 UTC · Open in terminal